The Potential Risk of Povidone-Iodine in Sperm Quality: A Case Report.

IF 1.8 4区 医学 Q3 DERMATOLOGY Journal of Drugs in Dermatology Pub Date : 2025-03-01 DOI:10.36849/JDD.7342
Fei Shi, Ling Wang, Changying Xing, Yannan Yang, Yubing Liu, Yunjing Xue, Sanwei Guo, Ri-Cheng Chian
{"title":"The Potential Risk of Povidone-Iodine in Sperm Quality: A Case Report.","authors":"Fei Shi, Ling Wang, Changying Xing, Yannan Yang, Yubing Liu, Yunjing Xue, Sanwei Guo, Ri-Cheng Chian","doi":"10.36849/JDD.7342","DOIUrl":null,"url":null,"abstract":"<p><p>To report a rare case of severe oligoasthenoteratozoospermia which seems to be associated with long-term topical povidone-iodine (PVP-I) therapy. A 45-year-old man with secondary infertility was diagnosed with mild asthenospermia before undergoing in vitro fertilization (IVF). A repeat sperm analysis (SA) on June 30, 2022, after three months of using compound PVP-I liniment to treat fungal infection under a fingernail and toenail, revealed severe oligoasthenoteratozoospermia. After 77 days of drug withdrawal, sperm concentration, and normal morphology gradually returned to normal, but motility was only partially restored. It seems that the usage of PVP-I has a side effect of causing a decline in sperm quality. Although the exact mechanism of this adverse effect of PVP-I is unclear, men who are in fertility treatment should be informed of the potential risks. J Drugs Dermatol. 2025;24(3):e11-e13.&nbsp; doi:10.36849/JDD.7342.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"24 3","pages":"e11-e13"},"PeriodicalIF":1.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.7342","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

To report a rare case of severe oligoasthenoteratozoospermia which seems to be associated with long-term topical povidone-iodine (PVP-I) therapy. A 45-year-old man with secondary infertility was diagnosed with mild asthenospermia before undergoing in vitro fertilization (IVF). A repeat sperm analysis (SA) on June 30, 2022, after three months of using compound PVP-I liniment to treat fungal infection under a fingernail and toenail, revealed severe oligoasthenoteratozoospermia. After 77 days of drug withdrawal, sperm concentration, and normal morphology gradually returned to normal, but motility was only partially restored. It seems that the usage of PVP-I has a side effect of causing a decline in sperm quality. Although the exact mechanism of this adverse effect of PVP-I is unclear, men who are in fertility treatment should be informed of the potential risks. J Drugs Dermatol. 2025;24(3):e11-e13.  doi:10.36849/JDD.7342.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
聚维酮碘对精子质量的潜在风险:1例报告。
报告一例罕见的严重少弱无畸形精子症,似乎与长期外用聚维酮碘(PVP-I)治疗有关。一例45岁男性继发性不孕症患者在接受体外受精(IVF)前被诊断为轻度弱精子症。在使用复方PVP-I搽剂治疗指甲和脚趾甲真菌感染三个月后,于2022年6月30日进行了重复精子分析(SA),发现严重的少弱无畸形精子症。停药77天后,精子浓度和形态逐渐恢复正常,但运动能力仅部分恢复。使用pvp - 1似乎有导致精子质量下降的副作用。尽管PVP-I的不良反应的确切机制尚不清楚,但应告知接受生育治疗的男性其潜在风险。皮肤医学杂志,2025;24(3):e11-e13。doi: 10.36849 / JDD.7342。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
289
审稿时长
3-6 weeks
期刊介绍: The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.
期刊最新文献
Efficacy and Safety of Cysteamine-Isobionic Amide Complex in the Treatment of Periorbital Hyperpigmentation. A Systematic Evaluation of Mpox Public Health Educational Resources. Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex. ChatGPT and DeepSeek in Dermatologic Practice: Do Artificial Intelligence Models Adhere to Psoriasis Treatment Guidelines? Pentoxifylline as a Steroid-Sparing Agent in Granuloma Annulare: A Rural Retrospective Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1